Literature DB >> 10172730

Economic outcomes for the treatment of allergic rhinitis.

C M Kozma1, M K Sadik, M L Watrous.   

Abstract

The purpose of this article is to review the literature related to economic outcomes associated with treating allergic rhinitis. A literature review was conducted using 'Medline' and the in-house database of the publishers of this journal for articles published between January 1991 and January 1996. Only 3 cost-outcome analyses that compared alternative treatments for allergic rhinitis were found. Given the limited number of full economic evaluations, much of this article focuses on issues related to direct and indirect costs and outcome measures that should be considered when performing an economic evaluation of allergic rhinitis. We conclude that more comprehensive analyses using a wide array of costs and outcomes are needed. At present, it is not possible to draw general conclusions regarding the economic value of alternative treatments for allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10172730     DOI: 10.2165/00019053-199610010-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  25 in total

Review 1.  Rhinitis and asthma.

Authors:  M Kaliner; R Lemanske
Journal:  JAMA       Date:  1992-11-25       Impact factor: 56.272

Review 2.  Immunotherapy in allergic respiratory diseases.

Authors:  D Vervloet; X van der Brempt; D Charpin; J Birnbaum
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Asthma and allergic rhinitis among Finnish adolescents in 1977-1991.

Authors:  A H Rimpelä; B Savonius; M K Rimpelä; T Haahtela
Journal:  Scand J Soc Med       Date:  1995-03

4.  Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

Authors:  E F Juniper; G H Guyatt
Journal:  Clin Exp Allergy       Date:  1991-01       Impact factor: 5.018

5.  Assessing and treating rhinitis. A practical guide for Canadian physicians. Proceedings of the Canadian Rhinitis Symposium. Toronto, Ontario, Canada. January 14-15, 1994.

Authors: 
Journal:  CMAJ       Date:  1994-08-15       Impact factor: 8.262

6.  Seasonal allergic rhinitis and antihistamine effects on children's learning.

Authors:  E F Vuurman; L M van Veggel; M M Uiterwijk; D Leutner; J F O'Hanlon
Journal:  Ann Allergy       Date:  1993-08

Review 7.  Hayfever in the United Kingdom.

Authors:  V Varney
Journal:  Clin Exp Allergy       Date:  1991-11       Impact factor: 5.018

8.  Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis.

Authors:  R J Dockhorn; A Bergner; J T Connell; C J Falliers; S V Grabiec; J M Weiler; M K Shellenberger
Journal:  Ann Allergy       Date:  1987-06

9.  Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.

Authors:  M Prevost; Y Turenne; D W Moote; J Mazza; A Clermont; C PetitClerc; M R Danzig
Journal:  Clin Ther       Date:  1994 Jan-Feb       Impact factor: 3.393

10.  Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.

Authors:  V A Varney; M Gaga; A J Frew; V R Aber; A B Kay; S R Durham
Journal:  BMJ       Date:  1991-02-02
View more
  6 in total

1.  Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.

Authors:  P K Schädlich; J G Brecht
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 2.  Ebastine: an update of its use in allergic disorders.

Authors:  M Hurst; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Cost effectiveness of nasal budesonide versus surgical treatment for nasal polyps.

Authors:  Fredrik Berggren; Leif Johansson
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.

Authors:  K Simpson; B Jarvis
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 5.  Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis.

Authors:  L R Wiseman; P Benfield
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 6.  Mometasone furoate. A review of its intranasal use in allergic rhinitis.

Authors:  S V Onrust; H M Lamb
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.